Replies to post #97466 on Quantum Materials Corp. (fka QTMM)

[drugmanrx]

Or they could be coming out of Assam India, as the April 4 2020 stated

I'm assuming gold nanoparticles are commodities and not terribly high tech or QMC would have problems with composition of matter patents. Assuming the tests currently approved are Xiamen's, they obviously have access to them in China.

"So we have an advantage. We have teamed with people like Quantum Materials Corporation of the USA. They are working on it and they are ready to help us achieve this target."

"We are kind of thinking that why not manufacture here nanoparticles, like gold nanoparticles or silver nanoparticles or carbon nanofibers, which we can make available to our, you know, locally. "

--------------------------------------------------------------------------------------------------------------------------------------
This unfortunately is more true than not.

I think it is ridiculously naïve to think Pasaca (or even Squires at this point) think of shareholders as anything more than an unfortunate burden that must be dealt with.

[TedJ]

"The QD's might just be colloidal gold particles which are spelled out in the respective EUA's."

I think you are missing the point of the slides. The majority of the common antibody and antigen LFDs (like Biotimes) do use colloidal gold/silver nanoparticles to bind to antibodies/antigens. And these are commodities and these tests are qualitative tests (antibodies present? yes/no).

But the slides present a different test approach that use molecular quantum dots. The point is this type of testing is more sophisticated and quantitative (how much of the different antibodies are present). These tests need the point of care laboratory grade reader to provide the results. These readers have existed prior to covid.

My guess is that the reader is not a new ground up development by QMC, Innova, Pasaca or Malan, but provided by someone else.

I would be happy if Innova is going to manufacture the lateral flow cassettes using quantum dots supplied by QMC. If Pasaca has another portfolio company that already is involved in POC readers, then they maybe supplied "in-house", but it not a necessity. And the QMCHID app and block chain ledger would tie things together with reporting.

So the "development of a functioning product integrating the QMC™ HealthID IP and Innova Medical Group, Inc.’s products" maybe the integration is QMC's ledger IP with a third party reader system.

[Kurt_Banoffee]

I don't know about that speculation regarding financial engineering and future corporate structure. On the other hand, I definitely expect Squires to get protected by stock awards as Pasaca dilutes the crap out of the individual investors shares.

How are they going to do that? There are only 61M authorized and unissued shares. I know the marketing consultants like to pretend that all the options, warrants, and convertibles don't count towards the total, but NV law says otherwise. The F/D must be 100's of millions over the A/S - just what we know about from the last 10-K tells us that - to say nothing for what's been issued since.

announced an equity investment from California-based private equity firm, Pasaca Capital, Inc. of $15 million and under terms of the distribution agreement formed between the two companies, Quantum Materials Corp would receive cumulative gross royalties and/or gross sales, licensing or other revenues of no less than $15,000,000, over the period including 2020 and continuing until twelve months after the Company has completed development of a functioning product integrating the QMC HealthID intellectual property and Innova Medical Group’s products.

What does this even mean? "Equity investment" = "gross royalties and/or gross sales, licensing or other revenues." WTF? Are these two different things? If so, what did Pascala get for their $15M? Not shares because even ignoring the derivatives, there aren't enough. So what just happened? Why can't we get a PR with a straight sensical answer that doesn't create more questions than it answers? Heck, we still have no idea what the deal is with QMVT.